Open original FDA record ↗Recall record
- FDA identifier
- Z-0735-2016
- Company in FDA record
- Owens & Minor Distribution, Inc.
- FDA classification date
- Jan 30, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
MediChoice sterile cohesive bandages imported and sold under a private brand by Owens & Minor were tested and found to have microbial contamination.
Source facts
- Action
- The firms recall strategy is as follows : recall was initiated by the Owens & Minor Home Office Recall Officer. The Home Office Recall Officer e-mailed the following documents to the Distribution Center (DC) Recall Officer at each affected DC: 1. DC Recall Letter (specific instructions for the DCs), 2. Recall Inventory Report form (for the DCs to record the amount of affected product quarantined), 3. Customer Letter (specific instructions for the customers), 4. Recall Return Response Form (for the customers to report back the details of the quantity of affected product in their inventory), 5. Attachment 1 (a document that provides examples of the product labeling), 6. Recall Checklist (a checklist for the DCs listing the actions that need to be completed), and 7. Recall Combine Queries spreadsheet (listing customers and current on-hand inventory at the DCs). The DC Recall Officer at each DC forwarded the information to the DC Customer Service team. The DC Customer Service team notified each impacted customer via e-mail or letter based upon the customers recorded preference. Level to which the recall was initiated: The recall was initiated to the level of the customer (i.e., hospitals, clinics, surgery centers). Follow-up plans: A minimum of three (3) attempts are made to obtain an acknowledgment from the customer that they received the recall notification. An attempt to determine the status of non-responsive businesses will be made. If the non-responsive business is still viable, an attempt will be made to determine the employee responsible for management of recalls and the recall notice will be sent to that employee. If the business is no longer viable, the steps described below for out-of-business accounts will be followed. Sub-recall: No sub-recall is required. These products are supplied to User Facilities and not distributed to commercial sub-accounts. Plans for effective checks: 1. Check records to ensure that the initial recall not
- Initiated
- 2015-11-17
- Root cause
- Under Investigation by firm
- Terminated
- 2016-09-13
- Distribution
- Nationwide Distribution.
- Recall number
- Z-0735-2016
- Recall status
- Terminated
- CDRH record ID
- 142889
- FDA classified
- 2016-01-30
- Recall event number
- 72910